Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Pulmonary/Respiratory Diseases | Vaccines | Infections and Infectious Diseases

Clinical Trials: Influenza


A listing of clinical trials currently looking for volunteers to enroll in Influenza studies. Click on the closest city to find more detailed information on a research study in your area.

Arkansas

Little Rock :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

California

Beverly Hills :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Burbank :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Los Angeles :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Los Angeles :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

San Diego :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

View More »

San Diego :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Stanford : Stanford University School of Medicine

Seasonal Influenza HA DNA (VRC) With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults Ages 18-70 Years

Colorado

Denver :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Connecticut

Trumbull :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Florida

Pinellas Park : Radiant Research - St. Petersburg

Clinical Research for Flu Vaccine

View More »

Coral Gables : Clinical Research of South Florida

Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults

Debary :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Miami : Miami Research Associates

Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years

Miami : Miami Research Associates

T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza

South Miami :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Tamarac :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Illinois

Chicago :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Chicago :

An Influenza Resistance Information Study (IRIS)

Maywood :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Iowa

Iowa City : University of Iowa Hospitals & Clinics

Seasonal Influenza HA DNA (VRC) With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults Ages 18-70 Years

Kansas

Lenexa : Johnson County Clin-Trials

Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years

Wichita :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Wichita :

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

Kentucky

Louisville :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Louisiana

New Orleans :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Maryland

Baltimore : SNBL Clinical Pharmacology Center

Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)

Massachusetts

Brockton : Beacon Clinical Research

65+ Flu Vaccine Research Study

View More »

Boston :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Springfield :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Michigan

Detroit :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Detroit :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Rochester : Remedica, LLC

Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults

Missouri

Kansas City : Dybedal Clinical Research Center

Influenza Study

View More »

St Louis :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

St. Louis : Saint Louis University - Doisy Research Center

Seasonal Influenza HA DNA (VRC) With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults Ages 18-70 Years

Nebraska

Omaha :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Omaha :

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

New Jersey

New Brunswick :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

New York

Rochester : Rochester Clinical Research

Elderly Flu Vaccine

View More »

Bronx :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Brooklyn :

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

New York :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

New York :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Stony Brook :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Stony Brook :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Syracuse :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

North Carolina

Cary : PMG Research of Cary

Flu Vaccine Coming in October

Charlotte : PMG Research of Charlotte

Flu Vaccine Coming in October

Hickory : PMG Research of Hickory

Flu Vaccine Coming in October

Raleigh : PMG Research of Raleigh

Flu Vaccine Coming in October

Salisbury : PMG Research of Salisbury

Flu Vaccine Coming in October

Wilmington : PMG Research of Wilmington

Flu Vaccine Coming in October

Winston-Salem : PMG Research of Winston-Salem

Flu Vaccine Coming in October

View More »

Charlotte :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Charlotte :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Durham :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Durham :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

North Dakota

Bismarck : St. Alexius Medical Center

A study of an investigational medication for the treatment of the flu

Ohio

Akron :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Toledo :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Oklahoma

Tulsa : Vital Prospects Clinical Research Institute, P.C.

Seasonal Flu

View More »

Oklahoma City :

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

Oregon

Eugene : Clinical Trials of America, Inc

Do you Currently Have the Flu?

Pennsylvania

Duncansville :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Philadelphia :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Pittsburgh :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Pittsburgh :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pittsburgh : University of Pittsburgh, Division of Geriatric Medicine

Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting

Rhode Island

Providence :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Tennessee

Knoxville : PMG Research of Knoxville

Flu Vaccine Coming in October

Texas

San Antonio : Sun Research Institute

Are you suffering from Flu-like symptoms?

San Antonio : Sun Research Institute

Are you suffering from Flu-like symptoms?

View More »

Dallas :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Dallas :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Houston :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Houston :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Houston : Baylor College of Medicine

Seasonal Influenza HA DNA (VRC) With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults Ages 18-70 Years

Virginia

Richmond :

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Australia

Brisbane : Taringa 7 Day Medical Practice

Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B

Brisbane : Capalaba Medical Centre

Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B

Westmead :

An Influenza Resistance Information Study (IRIS)

Belgium

Bruxelles :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Leuven :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Bulgaria

Plovdiv :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Canada

Burlington : Aviva Medical Clinical Trials Group

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Courtice : Co-Medica Research Network

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Halifax : QEII Health Science Centre

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Hamilton : McMaster

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Kitchener : Dr. Sameh Fikry Medicine Professional Corporation

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

View More »

London : Schacter Medicine Professional Corporation

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Mirabel : Omnispec Clinical Research Inc.

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Montreal : MUCH

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Montreal : Metropolitan Clinical Research Centre

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Oshawa : Taunton Health Centre

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Ottawa : Ottawa General

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Pickering : Steeple Hill Medical Centre

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Quebec : CHUl/CHUQ

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Quebec : ALPHA Recherche Clinique

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Saint John : Saint John Regional Hospital

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Sarnia : London Road Diagnostic Clinic and Medical Centre

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Sherbrooke : CHUS

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

St. John's : Paradise Medical Clinic

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Strathroy : DCTM Clinical Trials Group Ltd.

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Surrey : Fraser Health Authority

Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs)

Toronto : Mount Sinai Hospital

A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine

Toronto : Mount Sinai

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

Toronto : Dr. Anil Gupta

Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Vancouver : Vancouver General

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

China

Zhengzhou : Henan Center for Diseases Control and Prevention

The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine

Czech Republic

Decin : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Jindrichuv Hradec : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Lipnik nad Becvou : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Nachod : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Odolena voda : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

View More »

Ostrava - Poruba : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Parah 5 :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pardubice : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Praha 6 : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Tabor :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Terezin :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Zlin :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Estonia

Tallinn :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tartu :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

France

Bron :

An Influenza Resistance Information Study (IRIS)

Garches :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Paris :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Tours :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Germany

Berlin :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Berlin :

An Influenza Resistance Information Study (IRIS)

München :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Hong Kong

Shatin :

An Influenza Resistance Information Study (IRIS)

Hungary

Budapest :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Debrecen :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Eger :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Gyor :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Gyula :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

View More »

Miskolc :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Nyiregyhaza :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Pecs :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Pecs :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Szeged :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Szekesfehervar :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Szolnok :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Szombathely :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Veszprem :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Israel

Jerusalem : Hadassah medical center

A Study to Assess the Safety and Immunogenicity of an IM Influenza Vaccine (Multimeric-001) Followed by Administration of TIV to Elderly Volunteers

Petach Tikva :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tel Hashomer :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Italy

Brescia :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Milano :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Monza :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Roma :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Roma :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Kenya

Kisumu : KEMRI/CDC- IEIP surveillance-Asembo

Seasonal Influenza Vaccine Effectiveness Study in Kenya

Nairobi : KEMRI/CDC IEIP surveillance- Kibera

Seasonal Influenza Vaccine Effectiveness Study in Kenya

Latvia

Riga :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Lithuania

Kaunas :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Kaunas :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Klaipeda :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Siauliai :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Vilnius :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Norway

Sandnes :

An Influenza Resistance Information Study (IRIS)

Poland

Bialystok :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Bydgoszcz :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Chorzow :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Debica : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Katowice : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

View More »

Krakow :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Lodz :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Radom :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Siemianowice Slaskie : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Warszawa :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Wroclaw :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Romania

Bucharest :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Russian Federation

Saratov :

A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold

Spain

Alicante :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Almería :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Antequera/Málaga : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Blanes (Girona) : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Castellón : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

View More »

Centelles (Barcelona) : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Madrid :

A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Madrid :

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Madrid : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Paiporta, Valencia : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Quart de Poblet, Valencia : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Santiago de Compostela : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Sevilla : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Valencia : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Taiwan

Taoyuan County : Chang Gung Memorial Hospital at Linkuo

A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old

United Kingdom

Belfast : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Bristol : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Coventry : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

London :

Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza